Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Other Operating Expenses (2019 - 2025)

Updated

Korro Bio (KRRO) posted Other Operating Expenses of $34.51 million for Q4 2025.

Analysis

Korro Bio (KRRO) Other Operating Expenses (2019 - 2025) Analysis & Trends

For FY2025, Korro Bio's Other Operating Expenses came in at $30.89 million.

  • The Q4 2025 figure stands as the lowest quarterly Other Operating Expenses since Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korro Bio 281.05 Mn -128.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 30.89 Mn
Sep 30, 2019 16.00 Mn
API Access

Korro Bio Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEY